NEW YORK--(BUSINESS WIRE)--Americord, the fastest growing cord blood bank in the country, and a leader in the advancement of umbilical cord blood, cord tissue, and placenta tissue banking, announces the launch of its Cord Blood Topic Center.
Recognizing that expectant parents and new mothers have questions about stem cells, their potentially life-saving benefits, and ways to preserve them for future use, Americord has created a library of articles on a range of relevant topics. From pregnancy tips and birth planning to stem cell science and clinical trials, the content is focused on healthy pregnancies and growing families.
“We are excited to launch our new Topic Center to provide the resources expectant parents need to make informed decisions about stem cells and cord blood banking,” commented Erin Willigan, Vice President of Marketing for Americord. “We are committed to providing our current and future clients with informative content that offers insights, expertise, and unbiased advice during their pregnancy and beyond.”
The Cord Blood Topic Center is now live at topics.americordblood.com.
About Americord Registry
Americord Registry is a leader in the advancement of umbilical cord blood, cord tissue and placenta tissue banking. Americord collects, processes, and stores newborn stem cells from umbilical cord blood for future medical or therapeutic use, including the treatment of more than 80 blood diseases such as sickle cell anemia and leukemia. Founded in 2008, Americord is registered with the FDA and operates in all 50 states. The company’s laboratory is CLIA Certified and complies with all federal and state guidelines and applicable licenses. Americord is headquartered in New York, NY. You may visit Americord Registry’s website at www.americordblood.com for more information.